Rheumatoid arthritis(RA)is a chronic inflammatory and destructive arthropathy with a high deformity rate.Despite numerous studies and clinical trials,no curative treatment is available for large weight-bearing
the possibility of decreasing separation time through microchip electrophoresis (MCE, giving rise to MCE-SDS) has attracted major interest since the advantages it offers: faster separation times than CE-SDS (45 s vs 50 min), high throughput (400 vs 24 injections/day) while maintaining resolution...
Reagents including pristine (2, 6, 10, 14-tetramethylpentadecane, as inducing agent for arthritis) and methotrexate (4-amino-N10-methylpteroyl glutamic acid, as traditional anti-rheumatoid drug) injections were provided by Pfizer Pharmaceutical Factory (Australia). Lignin was kindly extracted from sug...
Eligible participants were aged鈮 18years, had a diagnosis of an indication of Acthar Gel based on the prescribing information, and had used Acthar Gel via SelfJect for 鈮 6 self-injections during the survey.Fifty-four participants completed the survey (mean age 55.4years, 76% women). Thirty...
Mechlorethamine caused fetal malformations in the rat and ferret when given as single subcutaneous injections of 1 mg/kg. Other findings in animals included embryo lethality and growth retardation when administered as a single subcutaneous injection. 8.2 Lactation Risk Summary There are no data on...
The safety of Restylane for use during pregnancy, in breastfeeding females or in patients under 18 years has not been established. Formation of keloids may occur after dermal filler injections including Restylane. Keloid formation was not observed in studies involving 430 patients (including 151 Afric...
The safety of Restylane for use during pregnancy, in breastfeeding females or in patients under 18 years has not been established. Formation of keloids may occur after dermal filler injections including Restylane. Keloid formation was not observed in studies involving 430 patients (including 151 Afric...
of pharmacologically active agent, a sustained, controlled release of the pharmacologically active agent is achieved, while reducing the initial high concentration effects that can be associated with other devices that include pharmacologically active agents or bolus injections of pharmacologically active ...
Gillis T, Crane M, Hinkle C, Wei N. Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action. Open Access Rheumatol. 2017;9:131-138....
of pharmacologically active agent, a sustained, controlled release of the pharmacologically active agent is achieved, while reducing the initial high concentration effects that can be associated with other devices that include pharmacologically active agents or bolus injections of pharmacologically active ...